| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Drug Discovery | SVP, Drug Discovery
1 company
Empfield James R. is an EVP, Drug Discovery at Xenon Pharmaceuticals Inc.. Recent SEC Form 4 filings include 1 buy and 5 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | XENE Xenon Pharmaceuticals Inc. | EVP, Drug Discovery | Sale+OE | 57,743 | $38.31 | $2,211,978.44 | -58.0% | -8.2% | -0.5% | |
| Mar 7, 2022 | XENE Xenon Pharmaceuticals Inc. | EVP, Drug Discovery | Sale+OE | 51,168 | $30.63 | $1,567,393.87 | -45.6% | -0.9% | +19.3% | |
| Aug 15, 2017 | XENE Xenon Pharmaceuticals Inc. | SVP, Drug Discovery | Buy | 10,000 | $2.48 | $24,824.00 | New | - | - |